Literature DB >> 8557648

Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes.

J W Adams1, D S Migita, M K Yu, R Young, M S Hellickson, F E Castro-Vargas, J D Domingo, P H Lee, J S Bui, S A Henderson.   

Abstract

Prostaglandin F2 alpha (PGF2 alpha) stimulates protein synthesis of skeletal and smooth muscle cells in culture and is elevated in the heart during compensatory growth. We hypothesized that PGF2 alpha stimulates hypertrophic growth of neonatal rat cardiac myocytes. Prostaglandin F2 alpha increased [3H]phenylalanine incorporation by cultured ventricular myocytes in a dose-dependent manner (EC50 = 11 nM), suggesting action through a PGF-specific receptor. Semiquantitative reverse transcriptase polymerase chain reaction revealed that PGF receptor mRNA is expressed in ventricular myocytes > A7R5 vascular smooth muscle cells >> cardiac fibroblast-like cells. The protein content of cardiomyocyte cultures was increased by 10 nM PGF2 alpha and 11 beta-PGF2 alpha but was unchanged by 10 nM PGD2, PGE2, PGF1 alpha, carbaprostacyclin, U-46619, or 12- or 15-hydroxyeicosatrienoic acid. Stimulation of myofibrillar gene expression by PGF2 alpha was demonstrated by Northern and Western blot analysis for myosin light chain-2 (MLC-2) and by transient transfection experiments with MLC-2 luciferase expression plasmids. In addition, myofibrillogenesis was increased by PGF2 alpha as assessed by immunocytochemical staining with MLC-2 antisera. Prostaglandin F2 alpha did not affect myocyte proliferation or [3H]thymidine incorporation, thus myocyte growth occurred by hypertrophy. Proliferative and hypertrophic growth of cardiac fibroblast-like cells were unaffected by PGF2 alpha. We conclude that PFG2 alpha stimulates hypertrophic growth of neonatal rat ventricular myocytes in culture and speculate that PGF2 alpha plays a role in myocardial adaptation to chronic hypertrophic stimuli, recovery from injury, and cardiac ontogeny.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557648     DOI: 10.1074/jbc.271.2.1179

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice.

Authors:  D D D'Angelo; Y Sakata; J N Lorenz; G P Boivin; R A Walsh; S B Liggett; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

3.  Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.

Authors:  Yanbin Liang; Chen Li; Victor M Guzman; William W Chang; Albert J Evinger; Jozelyn V Pablo; David F Woodward
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

4.  Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice.

Authors:  John M Streicher; Kenichiro Kamei; Tomo-o Ishikawa; Harvey Herschman; Yibin Wang
Journal:  J Mol Cell Cardiol       Date:  2010-02-17       Impact factor: 5.000

5.  RGS4 and RGS5 are in vivo substrates of the N-end rule pathway.

Authors:  Min Jae Lee; Takafumi Tasaki; Kayoko Moroi; Jee Young An; Sadao Kimura; Ilia V Davydov; Yong Tae Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

Review 6.  Eicosanoid signalling pathways in the heart.

Authors:  Christopher M Jenkins; Ari Cedars; Richard W Gross
Journal:  Cardiovasc Res       Date:  2008-12-14       Impact factor: 10.787

7.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  PGF2alpha-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN.

Authors:  K M Rice; S Uddemarri; D H Desai; R G Morrison; R Harris; G L Wright; E R Blough
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-11-17       Impact factor: 3.072

9.  Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice.

Authors:  S Offermanns; L P Zhao; A Gohla; I Sarosi; M I Simon; T M Wilkie
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

10.  Reduced troponin I phosphorylation and increased Ca(2+)-dependent ATP-consumption in triton X-skinned fiber preparations from Galphaq overexpressor mice.

Authors:  C Pott; L Willkomm; S Grafweg; B Bölck; G W Dorn; R H G Schwinger; K Brixius
Journal:  Mol Cell Biochem       Date:  2008-05-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.